Recent approaches in acute lymphoblastic leukemia in adults

This publication has 22 references indexed in Scilit:

• Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia
  Journal of Clinical Oncology, 2000
• Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin
  Leukemia, 1998
• Improved outcome of adult acute lymphoblastic leukaemia by moderately intensified chemotherapy which includes a ‘pre‐induction’ course for rapid tumour reduction: preliminary results on 66 patients
  British Journal of Haematology, 1998
• Intensification of treatment for adults with acute lymphoblastic leukaemia: results of U.K. Medical Research Council randomized trial UKALL XA
  British Journal of Haematology, 1997
• The GIMEMA ALL 0183 trial: analysis of 10‐year follow‐up
  British Journal of Haematology, 1996
• Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia
  British Journal of Haematology, 1993
• Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report
  Blood, 1991
• The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group B.
  Journal of Clinical Oncology, 1991
• Improved results of an intensified therapy in adult acute lymphocytic leukemia
  Annals of Oncology, 1991
• Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia.
  Journal of Clinical Oncology, 1990